The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended several new medicines at its December meeting, including submissions from Hansoh and Cytokinetics. The data byte reports five drug and vaccine recommendations, reflecting active regulatory momentum in Europe for novel therapeutics. Those CHMP endorsements will feed pending European Commission decisions and influence commercialization timelines across the region.